SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-067159
Filing Date
2015-08-20
Accepted
2015-08-20 18:02:08
Documents
2
Period of Report
2015-08-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1586
2 EX-24 DOCUMENT attachment1.htm EX-24 3087
  Complete submission text file 0001209191-15-067159.txt   6113
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ESSEX WOODLANDS HEALTH VENTURES 435 TASSO STREET, SUITE 350 PALO ALTO CA 94301
Business Address
Himawan Jeff (Reporting) CIK: 0001342821 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 151067144